Accueil・Liste d'Actions・Novocure Ltd

Novocure Ltd

Fermé

SecteurSoins de santé

16.92 -2.48

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

16.64

Max

17.36

Chiffres clés
By Trading Economics
Revenu	55M -16M
Ventes	9.5M 184M
BPA	-0.13
Marge bénéficiaire	-8.529
Employés	1,605
EBITDA	53M -11M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+74.04% upside

Dividendes
By Acuity
Prochains Résultats	29 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	169M 2B
Ouverture précédente	19.4
Clôture précédente	16.92

Sentiment de l'Actualité

By Acuity

55%

45%

281 / 340 Classement par Healthcare

Novocure Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13 août 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12 août 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11 août 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10 août 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8 août 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7 août 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6 août 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5 août 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4 août 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3 août 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31 juil. 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30 juil. 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29 juil. 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28 juil. 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27 juil. 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24 juil. 2026, 19:41 UTC

News

Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22 juil. 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

20 juil. 2026, 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Comparaison

Variation de prix

Novocure Ltd prévision

Objectif de Prix

By TipRanks

74.04% hausse

Prévisions sur 12 Mois

Moyen 29.5 USD 74.04%

Haut 52 USD

Bas 17 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

Achat

Maintien

Vente

Basé sur 4 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

281 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.